Durham gene therapy firm Kriya adds $270M in Series C funding to advance pipeline, expand in Triangle
Kriya Therapeutics, Inc., a gene therapy company with locations in California and RTP, has raised $270 million more in capital.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
